Close
Nordic 9Nordic 9

Milky Way Investments Group (investor - Others)

United Kingdom
See something wrong or missing? Let us know
Offices:London

Milky Way Investments Group is an investment holding operated by Nicholas Lane and Despoina Zinonos, via vehicles registered in the British Virgin Islands

Average round investment:40M USD
Average number per year:1.0
Distribution: 2025 (1)2024 (1)
Portfolio companies: United Kingdom bit.bio
Mostly invests in: United Kingdom United Kingdom (2) Biotech (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Milky Way Investments Group

Name Criteria
United States Charles River Laboratories
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Competitive Intelligence, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Ubiquity Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Competitive Intelligence, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Tekfen Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Netherlands Paul Polman
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Competitive Intelligence, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Netherlands Feike Sijbesma
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Competitive Intelligence, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Canada Radical Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Norway p53 Invest
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Arab Emirates Oryx Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States NYBC Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Bulgaria Ayana Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Competitive Intelligence, Health services, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top